Back to Search
KEVIN BLUME, D.O
D.O
Otolaryngology/Facial Plastic Surgery Physician
NPI: 1730539800IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology/Facial Plastic Surgery PhysicianPrimary
Otolaryngology — Otolaryngology/Facial Plastic Surgery
Code: 207YX0905X
5101022462(MI)009086(AZ)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
DES MOINES UNIVERSITY OF OSTEOPATHIC MEDICINE AND HEALTH SCIENCES
Class of 2016
Research & Publications (20)
A rare combination of two inherited disorders in one patient: pyruvate kinase deficiency and hemochromatosis.
PMID 19137298·Ann Hematol·2009
5-case
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.
PMID 19423725·Blood·2009
3-trial
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
PMID 18940683·Biol Blood Marrow Transplant·2008
4-observational
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
PMID 18215785·Biol Blood Marrow Transplant·2008
3-trial
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.
PMID 18519812·Blood·2008
8-other
HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex.
PMID 18854243·Cell Host Microbe·2008
8-other
Novel (n)PKC kinases phosphorylate Nef for increased HIV transcription, replication and perinuclear targeting.
PMID 17904606·Virology·2008
7-preclinical
Induction of HIV transcription by Nef involves Lck activation and protein kinase C theta raft recruitment leading to activation of ERK1/2 but not NF kappa B.
PMID 19050260·J Immunol·2008
4-observational
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 17595333·Blood·2007
8-other
Altered sexual health and quality of life in women prior to hematopoietic cell transplantation.
PMID 17196431·Eur J Oncol Nurs·2007
8-other
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
PMID 16545729·Biol Blood Marrow Transplant·2006
3-trial
High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
PMID 16785059·Biol Blood Marrow Transplant·2006
8-other
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
PMID 16545728·Biol Blood Marrow Transplant·2006
3-trial
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
PMID 15682068·Biol Blood Marrow Transplant·2005
3-trial
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
PMID 15800667·Leukemia·2005
3-trial
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
PMID 15809448·J Clin Oncol·2005
4-observational
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
PMID 15842663·Br J Haematol·2005
8-other
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
PMID 15983549·Biol Blood Marrow Transplant·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 395 N SILVERBELL RD STE 201
TUCSON, AZ 85745 - Phone
- (520) 792-2170
Quick Facts
- NPI
- 1730539800
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile